Results 41 to 50 of about 13,175 (206)

SARS-CoV-2 and Anti-Cardiolipin Antibodies

open access: yesClinical Medicine Insights: Case Reports, 2020
The current COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to distinct diagnostic and management challenges for front-line healthcare workers. The risk of excessive coagulation activation leading to a
Mazen Jizzini, Mohsin Shah, Kehua Zhou
doaj   +1 more source

Lepromatous leprosy simulating rheumatoid arthritis - Report of a neglected disease [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
Brazil has the second largest number of leprosy cases in the world; nevertheless, late diagnosis is common. We report the case of a male patient with pain and numbness in both hands and feet for six years with positive rheumatoid factor and ...
Tatiana Cristina Pedro Cordeiro de Andrade   +5 more
doaj   +1 more source

Successful Treatment of Severe Purpura Fulminans With Anakinra

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Purpura fulminans (PF) is a rare, often fatal pediatric condition characterized by intravascular thrombosis and hemorrhagic infarction of the skin. A timely diagnosis and treatment are paramount to prevent the involvement of internal organs, causing disseminated intravascular coagulation and gangrene of the extremities.
Francesco Zulian   +4 more
wiley   +1 more source

Correlation of anti-cardiolipin antibodies with right ventricular systolic strain in systemic lupus erythematosus patients

open access: yesEgyptian Journal of Critical Care Medicine, 2017
Introduction: The association between anticardiolipin antibodies (aCL) and cardiac disease in the presence of systemic lupus erythematosus (SLE) has been reported in various clinical trials.
Hatem Abdel Rahman Helmy   +5 more
doaj   +1 more source

Hepatic venous outflow block in a young patient with Systemic Lupus Erythematosus [PDF]

open access: yesJournal of Analytical Research in Clinical Medicine, 2015
Introduction: Hepatic venous outflow block or Budd-Chiari syndrome is a severe liver disease with a 3 years survival rate of 50%. Several conditions have been implicated as a cause of Budd-Chiari syndrome, including myeloproliferative disorders ...
Ali Ghavidel
doaj   +1 more source

Anticardiolipin antibodies in patients with Behcet's disease

open access: yesBiomolecules & Biomedicine, 2011
The aims of this study are to determine anticardiolipin antibodies in patients with Sy Behcet and to determine correlation between the levels of anticardiolipin antibodies in serum in patients with clinic systemic and ocular manifestations.
Maja Zivkovic   +4 more
doaj   +1 more source

Laboratory Identification of Lupus Anticoagulant (LA) Using Different Activated Partial Thromboplastin Time (APTT) Assays

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 1, Page 172-178, February 2026.
ABSTRACT Introduction The International Society of Thrombosis and Hemostasis (ISTH) guidelines suggest a three‐step evaluation for the detection of lupus anticoagulant (LA), including screening, mixing, and confirmation. According to the guidelines, the LA assay based on activated partial thromboplastin time (APTT) should include an initial screening ...
Bárbara G. Barion   +7 more
wiley   +1 more source

Facts and Misfacts on D‐Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis (SISET)

open access: yesAmerican Journal of Hematology, Volume 101, Issue 1, Page 97-109, January 2026.
ABSTRACT D‐dimer defines degradation products derived from the proteolysis mediated by plasmin on cross‐linked fibrin. The evidence‐based use of D‐dimer in some conditions has been consolidated. Currently, however, there is an entrenched prescription of D‐dimer testing to screen otherwise healthy subjects that may induce prescribing physicians to start
Armando Tripodi   +11 more
wiley   +1 more source

Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria

open access: yesAntibodies
Catastrophic antiphospholipid syndrome (CAPS) is a rare and life-threatening condition characterized by the persistence of antiphospholipid antibodies and occurrence of multiple vascular occlusive events. CAPS currently remains a diagnostic challenge and
Lucas Jacobs   +4 more
doaj   +1 more source

High Prevalence of aCL-IgA and aβ2GPI-IgA in Drug-Free Schizophrenia Patients: Evidence of a Potential Autoimmune Link

open access: yesAntibodies
Background/Objectives: Schizophrenia (SZ) is a complex psychiatric disorder with increasing evidence pointing to an autoimmune component, including the presence of antiphospholipid antibodies (aPLs).
Samar Samoud   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy